Company news
Avenir Wellness Solutions Inc. (OTC:AVRW) news
Avenir Wellness Solutions Inc. news releases on 6ix. Latest, May 1, 2019: CURE Pharmaceutical Extends Closing Of Privately-Held Chemistry Holdings Inc.…
Press releases — page 3
CURE Pharmaceutical Extends Closing Of Privately-Held Chemistry Holdings Inc. Acquisition to May 13
May 1, 2019
Cure Pharmaceutical [OTCQB:CURR] to Present at the “Planet MicroCap Showcase 2019”
April 30, 2019
CURE Pharmaceutical Named “Innovative Business of the Year” By Oxnard Chamber of Commerce
April 26, 2019
United Smart Cities and Cure Pharmaceutical Launch Global Healthcare Awareness Initiative
April 9, 2019
CURE Pharmaceutical to Acquire Privately-Held Chemistry Holdings Inc., Expanding Its Technology Platform in Oral Drug Delivery
April 1, 2019
CURE Pharmaceutical Announces Completion of FDA Pre-IND Review and Clinical Trial Plans for CUREfilm Blue™ for Erectile Dysfunction
March 26, 2019
CURE Pharmaceutical Expands U.S. DEA Approval to Manufacture Pharmaceuticals Using Whole Cannabis Plant
March 12, 2019
National Healthcare Economics and Policy Expert Ruben Jose King-Shaw Jr Joins CURE Pharmaceutical’s Board of Directors
January 29, 2019
CURE Pharmaceutical Appoints Chairman, Adds Member to its Board of Directors
January 15, 2019
CURE Pharmaceutical To Present at Benzinga Cannabis Capital Conference
January 9, 2019
CURE Pharmaceutical Secures U.S. DEA Approval to Manufacture Cannabinoid-based Pharmaceuticals
November 26, 2018
CURE Pharmaceutical Names Veteran Executive as Chief Financial Officer
November 14, 2018
Prominent Biotech Investor Gene Salkind Adds Another $2M Investment in CURE Pharmaceutical
November 1, 2018
CURE Pharmaceutical to Present at CannX 2018 International Medical Cannabis Conference
October 10, 2018
CURE Pharmaceutical to Present at The MicroCap Conference on October 1st and 2nd in New York City at the Essex House
September 28, 2018
CURE Pharmaceutical Secures Patent for Oral Thin Film Containing Bioactive Cannabinoid Molecules
September 25, 2018
CURE Pharmaceutical Expands Distribution of CUREfilm Technology with First Licensing Agreement
September 5, 2018
Cure Pharmaceutical Plans to Acquire Cannabinoid-Based Drug Pipeline from Therapix Biosciences Ltd.
July 11, 2018
CURE Pharmaceutical to Present on the Increased Bioavailability for Cannabinoids Due to New Delivery Technologies at O’Cannabiz Conference
June 5, 2018
CURE Pharmaceutical to Showcase Company Growth at the 8th LD Micro Invitational
May 23, 2018
CURE Pharmaceutical Attracts Strategic Investment to Speed Its Cannabinoid Drug Delivery Production
May 1, 2018
CURE Pharmaceutical Secures Two Patents for the Extraction and Purification of Bioactive Cannabinoid Molecules
April 4, 2018
CURE Pharmaceutical Reports Strong Progress and Sets Growth Roadmap for Remainder of Year
April 3, 2018
CURE Pharmaceutical to Participate in Hawaiian Cannabis Science Dinner & Dialogue Panel to Discuss Company’s Research on the Endocannabinoid System for Breakthrough Therapies
March 23, 2018
CURE Pharmaceutical Announces Closing of $1 Million Bridge Financing and Prepares to Uplist to NASDAQ
March 23, 2018
UPDATED – Hawaii Cannabis Science Dinner & Dialogue Panel to Discuss Company’s Research on the Endocannabinoid System for Breakthrough Therapies
March 22, 2018
Biopharmaceutical Veteran Joins CURE Pharmaceutical to Lead Manufacturing
March 14, 2018
CURE Pharmaceutical Adds Healthcare Luminary To Advisory Board, Secures $1 Million Investment as a Bridge to Uplisting
February 21, 2018
CURE Pharmaceutical Adds New VP of Strategy and Business Development
January 25, 2018
CURE Pharmaceutical Launches New Brand Focused on Patient Needs in Medication Delivery
January 4, 2018
CURE Pharmaceutical to Present at 2018 Biotech Showcase
January 3, 2018
Cure Pharmaceutical Enters Into Product Development Agreement with Therapix Biosciences To Develop Cannabinoid-Based Product For Sleep Disorders
November 7, 2017
Oak Therapeutics Announces Results of Bioequivalence Study of Company’s Oral Dissolvable Strip for Tuberculosis
October 3, 2017
CureDots(TM) Look to Redefine How Animal Clinical Trials Are Conducted -- CFN Media
September 14, 2017
CURE Pharmaceutical Launches New Academic Partnership Program Providing the Company’s Proprietary CureFilm™ for More Humane and Effective Animal Research
September 6, 2017
CURE Pharmaceutical to Participate in Panel Discussion on the Future of Clinical Research using Cannabis at The Cannabis Science Conference in Portland, OR
August 29, 2017
CFN Media Exclusive Interview: CURE Pharma Discusses Vision & Breakthrough Technology
August 28, 2017
CURE Pharmaceutical Subsidiary, Oak Therapeutics, Completes Critical Milestone in Phase 1 of NIH Grant to Develop Oral Dissolvable Strip for Tuberculosis
August 22, 2017
CURE Pharma Could Take Over Where Zynerba Fell Short -- CFN Media
August 11, 2017
CURE Pharmaceutical Enters Partnership to Distribute New Erectile Dysfuntion Drug Using Company’s Proprietary CureFilm™ Into Asian Market
August 10, 2017
Top 4 Companies Reinventing Cannabinoid Delivery -- CFN Media
July 26, 2017
CURE Pharmaceutical & Therapix Biosciences Signs MOU with Israel’s Assuta Medical Centers to Develop First-in-Class Therapeutic Products in Fields of Personalized Medicine & Cannabinoids
July 11, 2017
CURE Pharmaceutical & Therapix Biosciences Signs MOU with Israel's Assuta Medical Center to Develop First-in-Class Therapeutic Products in Fields of Personalized Medicine & Cannabinoids
July 11, 2017
CURE Pharma Brings Innovative Drug Delivery to Cannabis & Beyond -- CFN Media
July 7, 2017
CURE Pharmaceutical Expects Increased Demand for Its Enhanced Transdermal Drug Delivery Platform
July 5, 2017
CURE Pharmaceutical Appoints CannaKids CEO and Cannabis Cancer Advocate Tracy Ryan to Advisory Board
June 27, 2017
CURE Pharma Looks to Revolutionize Cannabinoid Delivery
June 15, 2017
Leading OTF Manufacturer CURE Pharmaceutical Comments on New Report Showing Exponential Growth in Thin Film Drug Manufacturing Market
June 7, 2017
CURE Pharmaceutical and CannaKids Announce Research Collaboration with Technion-Israel Institute of Technology on Cancer-Fighting Cannabinoids
May 31, 2017
CURE Pharmaceutical Receives First Purchase Order Stemming from Product Development and License Agreement with Pharmaceutical Company, Meroven LTD.
May 24, 2017